EVAN CAPLAN

Evan Caplan is a distinguished Principal at OrbiMed, a globally recognized investment firm dedicated exclusively to the healthcare sector. As a key member of OrbiMed's investment team, Evan Caplan plays a pivotal role in identifying, evaluating, and executing investment opportunities across the firm's diverse strategies, which span venture capital, private equity, and public equity. His work is instrumental in OrbiMed's mission to support innovative companies that are shaping the future of medicine and patient care.

At OrbiMed, Evan Caplan's investment focus primarily centers on the dynamic and rapidly evolving fields of biotechnology, pharmaceuticals, and medical devices. He possesses a deep understanding of the scientific, clinical, and commercial landscapes within these sectors, allowing him to identify companies with strong potential for growth and significant impact. His expertise extends to evaluating novel therapeutics, cutting-edge diagnostics, and transformative medical technologies that address unmet medical needs and improve patient outcomes. Evan Caplan is actively involved in conducting thorough due diligence, market analysis, and financial modeling to assess potential investments, ensuring that OrbiMed backs companies poised for success.

Evan Caplan's career background reflects a strong foundation in finance and a dedicated commitment to the healthcare industry. Prior to his role as Principal at OrbiMed, he honed his analytical and strategic skills through various experiences that provided him with a comprehensive perspective on healthcare innovation and investment. This background equips him with the ability to navigate complex scientific data, regulatory pathways, and market dynamics, making him a valuable asset in OrbiMed's rigorous investment process. His contributions help OrbiMed maintain its position as a leader in healthcare investment, fostering the development of life-changing therapies and technologies.

While specific notable investments are often proprietary to the firm, Evan Caplan's involvement aligns with OrbiMed's broader portfolio, which includes a wide array of successful companies from early-stage startups to established public entities. His work contributes to OrbiMed's track record of backing companies that have brought significant advancements to patients worldwide. Through his strategic insights and diligent efforts, Evan Caplan helps OrbiMed continue its legacy of driving innovation and delivering strong returns within the global healthcare landscape.